DNAPrint Genomics, Inc. (DNAG)
DNAG Stock Price Chart
Explore DNAPrint Genomics, Inc. interactive price chart. Choose custom timeframes to analyze DNAG price movements and trends.
DNAG Company Profile
Discover essential business fundamentals and corporate details for DNAPrint Genomics, Inc. (DNAG) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Feb 2001
Employees
24.00
CEO
Jatin Patel
Description
DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.
DNAG Financial Timeline
Browse a chronological timeline of DNAPrint Genomics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
DNAG Stock Performance
Access detailed DNAG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.